GuideStar Eldercare

Get the latest PVC industry insights and technical updates delivered straight to your inbox.

Subscribe to the AM Stabilizers newsletter to be the first to know about our new technology initiatives and sustainability developments.

Sign up today > https://mailchi.mp/43f02612a86c/newsletter-signup

GuideStar Eldercare is improving quality of life for patients with Alzheimer’s disease using neurology-forward treatment.
Recent studies have found a pattern of improvement in rate of hospitalization, survivability, and overall quality of life for Alzheimer’s patients taking both Donepezil and Memantine in tandem.
Our latest blog post explores the impact that this drug combination is having for long-term care residents with Alzheimer’s disease and how this type of neurological treatment can be effective for a wide range of dementias and BPSD symptoms. https://loom.ly/aroZbKA

Cases of Parkinson’s disease are expected to double by 2030. But what do we really know about this common neurological condition?

On the GuideStar Eldercare blog, we provide an overview of the external and internal symptoms that make Parkinson’s disease so debilitating. We examine risk factors for Parkinson’s and explore how treatment of this disease will remain a priority for long-term care providers in the future.

Parkinson’s Awareness Month presents an opportunity to share and grow our knowledge base around this disease and to reveal how GuideStar Eldercare can help you and your staff to better ensure quality of life for patients with Parkinson’s. https://loom.ly/JZ-JuNw

Will your state be the next to adopt a Quality Incentive Program?
Long-term care providers in Ohio, Texas and other states are embracing a new incentive model that ties quality score improvements directly to Medicaid reimbursement. How do these programs work? Are they effective in improving outcomes for LTC patients?
We take a look at the numbers and assess the future of Quality Incentive Program (QIP) initiatives in our latest blog post. We also discuss the different ways GuideStar Eldercare can help promote effective Quality Management and operational excellence in your facilities. https://loom.ly/v2iOduA

March is Brain Injury Awareness Month. For the 11.4 million adults living with traumatic brain injury (TBI), receiving long-term care and maintaining quality of life can be an immense challenge.
In our latest blog, we highlight some new developments in traumatic brain injury treatment and build a case for how GuideStar Eldercare can help you to better serve TBI patients in your facility. https://loom.ly/VtUu3Ww

We are thrilled to announce that GuideStar Eldercare has chosen a new Chief Operating Officer — Stephanie Neely, RN. Neely brings over 32 years of experience in skilled nursing and innovative care to her new role. She has a proven track record in clinical operations, regulatory compliance, and multi-facility leadership, with deep expertise in survey readiness and both state and federal standards.

GuideStar President and CEO, Maureen Maloney says of Neely: “Stephanie is an outstanding addition as Chief Operating Officer. Her prior experience in skilled nursing facilities, combined with her strong clinical background, brings both strategic insight and operational expertise. She is uniquely positioned to strengthen client relationships, enhance our organizational and clinical performance, and ensure the highest level of care for our shared patients.” Steven Posar, MD, Founder, Executive Chair and Chief Medical Officer, also offered Neely his full support.

Welcome, Stephanie!

Nurses — help us close the gap in eldercare.
More qualified nurses are needed to properly treat dementia-related illnesses. GuideStar is proud to partner with Saint Mary’s College to offer a certificate in Geriatric Neuropsychiatry that can help you further your career — and become part of the solution.
This program combines neuroscience, geriatrics and psychiatric care to help you treat underlying causes and improve quality of life for your patients. Learn more on how you can earn your graduate certificate.
https://loom.ly/NoQFgS0

Are your residents at risk of adverse events with antipsychotics? Researchers explain the risk factors and how to know who is most vulnerable. Knowledge is power. Inform your decision-making with perspectives from the new blog, Risk-Benefit Analysis: Antipsychotics in Dementia Care. https://loom.ly/imm8saY

Is your nursing home ready to meet the new CMS Long-Stay Antipsychotic Quality Measure requirements? According to McKnights Long-Term Care News, the Centers for Medicare & Medicaid Services have begun issuing validation audit requests.https://loom.ly/w4VvQnU

New requirements are likely to raise the percentage of your residents who count toward the Long-Stay Antipsychotic Quality Measure score.

GuideStar’s neurology-forward model can help provide targeted, person-centered treatment for your residents, reducing the rate of antipsychotic usage in your facility. Find critical steps you can implement today on our blog. https://loom.ly/8hwyjP0

Gabapentin is the fifth most commonly prescribed drug in the U.S. Despite its popularity in nursing homes, geriatricians are raising red flags. Explore the research on gabapentin, BPSDs, anticonvulsants, and more in the new blog, Gabapentin Associated with Cognitive Decline & Dementia. https://loom.ly/FqLIKwU